Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

tolvaptan

tolvaptan
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Jynarque TABLET, ORAL 15 mg, 30 mg, 45 mg, 60 mg, 90 mg      
Samsca TABLET, ORAL 15 mg, 30 mg      
VIEW MORE Vasopressin Antagonists
CLASS
402828
Comments:

Jynarque medication guide

Samsca medication guide

SAMSCA is classified as formulary, restricted to cardiology, CV surgery, nephrology, or endocrinology.

Jynarque is non-formulary, not stocked. Drug is only distributed directly to the patient from a specialty pharmacy. If ordered for continuation of home use in the hospital, a nephrology consult is recommended. Inpatients should use their own Jynarque if at all possible, rather than Samsca tablets.

Reviewed: August 25, 2009, and 23 Oct 2018 (Jynarque)

Updated: May 2019 (PKS automatic consultation discontinued)

REMS (Jynarque): View FDA REMS Info

Last updated: Jan. 29, 2020






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved